Table 9.8a

Adjusted Graft Survival, Deceased Donor Liver Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

		3 Months			1 Year			3 Years			5 Years
		N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.
Total	All	9,143	88.2%	0.3%	9,143	81.5%	0.4%	8,722	72.1%	0.5%	8,194	65.2%	0.5%
Primary Diagnosis	Non-Cholestatic Cirrhosis	5,793	89.5%	0.4%	5,793	82.5%	0.5%	5,699	71.5%	0.6%	5,163	65.2%	0.7%
	Cholestatic Liver Disease/Cirrhosis	923	90.2%	1.0%	923	84.7%	1.2%	938	78.2%	1.4%	1,102	71.4%	1.4%
	Acute Hepatic Necrosis	765	82.4%	1.4%	765	74.2%	1.6%	822	68.6%	1.6%	689	61.4%	1.9%
	Biliary Atresia	330	81.9%	2.7%	330	78.6%	2.9%	340	81.3%	2.4%	391	65.1%	3.1%
	Metabolic Diseases	302	90.5%	1.7%	302	86.7%	2.0%	292	76.5%	2.5%	315	71.4%	2.6%
	Malignant Neoplasms	418	88.9%	1.5%	418	80.4%	1.9%	180	59.7%	3.6%	188	51.9%	3.6%
	Other	612	81.9%	1.6%	612	75.1%	1.8%	451	68.1%	2.2%	346	54.3%	2.8%

Source: OPTN/SRTR Data as of May 3, 2004.

(+) = Values not determined due to insufficient follow-up.

(-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during 2001-2002 for 3 month and 1 year; 1999-2000 for 3 year; and 1997-1998 for 5 year survival.

Graft survival follows individual transplants until graft failure.

Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on liver transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.